Logo image of TMCI

TREACE MEDICAL CONCEPTS INC (TMCI) Stock Analyst Earnings Estimates

NASDAQ:TMCI - Nasdaq - US89455T1097 - Common Stock - Currency: USD

9.37  -0.29 (-3%)

After market: 9.55 +0.18 (+1.92%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
TMCI revenue by date.TMCI revenue by date.
94.4M
64.46%
141.8M
50.21%
187.118M
31.96%
211.94M
13.27%
230.19M
8.61%
253.57M
10.16%
264.59M
4.35%
364.85M
37.89%
EBITDA
YoY % growth
TMCI ebitda by date.TMCI ebitda by date.
-15.81M
-849.29%
-32.67M
-106.64%
-46.076M
-41.03%
-13.242M
71.26%
-116.423K
99.12%
5.929M
5,192.65%
4.794M
-19.14%
34.374M
617.02%
EBIT
YoY % growth
TMCI ebit by date.TMCI ebit by date.
-16.5M
-1,933.33%
-34.8M
-110.91%
-51.428M
-47.78%
-59.122M
-14.96%
-45.389M
23.23%
-39.922M
12.04%
-44.37M
-11.14%
-21.726M
51.03%
Operating Margin
TMCI operating margin by date.TMCI operating margin by date.
-17.48%-24.54%-27.48%-27.90%-19.72%-15.74%-16.77%-5.95%
EPS
YoY % growth
TMCI eps by date.TMCI eps by date.
-0.41-0.77
-87.80%
-0.81
-5.19%
-0.95
-16.75%
-0.76
20.03%
-0.66
12.52%
-0.48
27.53%
-0.26
46.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.04
60.66%
-0.26
14.32%
-0.25
12.77%
-0.21
15.14%
-0.03
17.03%
-0.27
-5.16%
-0.25
1.21%
-0.17
20.67%
0.09
365.63%
Revenue
Q2Q % growth
68.5M
10.11%
54.174M
6.00%
50.484M
13.56%
50.004M
10.91%
76.873M
12.22%
59.124M
9.14%
55.085M
9.11%
55.437M
10.87%
86.21M
12.15%
EBITDA
Q2Q % growth
9.117M
737.55%
-6.299M
63.08%
-5.748M
66.89%
-2.037M
77.24%
14.308M
56.94%
-5.753M
8.66%
-4.881M
15.08%
984.3K
148.31%
20.14M
40.76%
EBIT
Q2Q % growth
-2.309M
65.96%
-16.516M
12.93%
-15.897M
25.65%
-12.584M
16.85%
2.55M
210.46%
-16.386M
0.79%
-15.28M
3.88%
-10.139M
19.43%
6.707M
163.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.25
10.71%
-0.280.039.78%
Q2 2024
Q2Q % growth
-0.29
-45.00%
-0.300.011.96%
Q1 2024
Q2Q % growth
-0.30
-30.43%
-0.310.012.89%
Q4 2023
Q2Q % growth
-0.10
-25.00%
-0.09-0.01-10.69%
Q3 2023
Q2Q % growth
-0.28
-27.27%
-0.27-0.01-5.00%
Q2 2023
Q2Q % growth
-0.20
35.48%
-0.240.0417.73%
Q1 2023
Q2Q % growth
-0.23
-43.75%
-0.230.001.24%
Q4 2022
Q2Q % growth
-0.08
33.33%
-0.140.0643.98%
Q3 2022
Q2Q % growth
-0.22
-83.33%
-0.290.0724.98%
Q2 2022
Q2Q % growth
-0.31
-210.00%
-0.21-0.10-48.25%
Q1 2022
Q2Q % growth
-0.16
-128.57%
-0.210.0522.54%
Q4 2021
Q2Q % growth
-0.12 -0.01-0.11-2,252.94%
Q3 2021
Q2Q % growth
-0.12 -0.120.001.96%
Q2 2021
Q2Q % growth
-0.10 -0.120.0218.30%
Q1 2021
Q2Q % growth
-0.07 -0.06-0.01-14.38%
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
45.086M
10.62%
44.354M732K1.65%
Q2 2024
Q2Q % growth
44.455M
5.96%
43.86M595K1.36%
Q1 2024
Q2Q % growth
51.108M
21.12%
50.046M1.062M2.12%
Q4 2023
Q2Q % growth
62.212M
25.00%
61.761M451K0.73%
Q3 2023
Q2Q % growth
40.758M
23.28%
42.896M-2.138M-4.98%
Q2 2023
Q2Q % growth
41.953M
39.98%
41.665M288K0.69%
Q1 2023
Q2Q % growth
42.195M
45.25%
40.03M2.165M5.41%
Q4 2022
Q2Q % growth
49.77M
48.83%
45.645M4.125M9.04%
Q3 2022
Q2Q % growth
33.06M
52.91%
30.668M2.392M7.80%
Q2 2022
Q2Q % growth
29.97M
45.13%
29.206M764K2.62%
Q1 2022
Q2Q % growth
29.05M
55.26%
26.554M2.496M9.40%
Q4 2021
Q2Q % growth
33.44M
38.76%
32.912M528K1.60%
Q3 2021
Q2Q % growth
21.62M
51.51%
21.42M200K0.93%
Q2 2021
Q2Q % growth
20.65M
166.80%
19.312M1.338M6.93%
Q1 2021
Q2Q % growth
18.71M
66.16%
19.142M-432K-2.26%
Q4 2020
Q2Q % growth
24.1M
43.97%
%
Q3 2020
Q2Q % growth
14.27M
60.52%
%
Q2 2020
Q2Q % growth
7.74M
-1.90%
%
Q1 2020
Q2Q % growth
11.26M
90.85%
%
TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.18% -5.18% -0.23% -0.23%
Revenue0.37% 0.37% 0% 0.1%